IRCT20080901001165N68 IRCT 2022-09-14 Bagheiat-allah University of Medical Sciences Evaluation of efficacy and safety of Detoxil capsules in patients with liver injury Evaluation of the efficacy and safety of Detoxil (a herbal medicine) in improving liver function in liver injury 2022-09-23 anticipated 100 Complete https://irct.ir/trial/63102 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block Randomization method is used to randomized the patients. In this method, the number of people assigned to each group is usually almost equal. Blocks are formed based on the considered variables and within each block, half of the people are involved and half are considered as witnesses. The main goal in this method is to balance the number of participants in each group, Blinding description: The placebo looks the same as the original drug, provided by the drug company. In this study, the prescribing physician, patient, therapeutic team, data collector, and statistical analyzer are unaware about type of intervention (intervention / placebo). 3 Diseases of liver. Intervention 1: Intervention group: oral Detoxil capsules 400mg, 1 capsule, every 12 hours for 5 days. Detoxil capsules are prepared by Tabib-Daru Pharmaceutical Company (located at Kashan) and contain hydroalcoholic extracts of sage, artichoke, dandelion and poppy extract with the 1:1 ratio. Intervention 2: Control group: oral placebo capsule 400mg, 1 capsule every 12 hours for 5 days. he placebo capsule with a appearance completely similar to the main drug has been prepared by Tabib-Daru Pharmaceutical Company (located at Kashan). Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is The data release schedule is still unclear